A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol
A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol
Deborah J. Wong, Maria A. Velez Velez, Mardi Santoso, Minsong Cao et al.
Citations
3 citations
Journal
BMC Cancer
Topics
Advanced Radiotherapy Techniques
Field-Weighted Citation Impact (FWCI)
1.82
article
A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol
Deborah J. Wong, Maria A. Velez Velez, Mardi Santoso, Minsong Cao, D O’Connell, Ricky R. Savjani, Vishruth K. Reddy, T. Vincent Basehart, Wanxing Chai‐Ho, P.T. Courtney, Donatello Telesca, Robert Chin, Christy Palodichuk
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
BMC CancerVol. 24(1)
Institutions
University of California, Los Angeles (US)
Funders
Varian Medical Systems, National Institutes of Health